Company Filing History:
1 out of 812 
1 out of 1,744 
1 out of 61 
Years Active: 2019
Title: Annabelle Rui Fen Lim: Innovator in Pertussis Vaccine Development
Introduction: Annabelle Rui Fen Lim is a prominent inventor based in Singapore, known for her significant contribution to biomedical research, particularly in the field of vaccine development. With one patent to her name, Lim has demonstrated her expertise in creating innovative solutions to combat infectious diseases.
Latest Patents: Annabelle's patent, titled "Prevention of Pertussis Using Adenylate Cyclase Deficient Bordetella Strains," involves the construction of a CyaA-deficient mutant strain that is utilized in a pertussis vaccine. The study reveals that the pertussis-specific antibody profile and Th17 response induced by the vaccination with this mutant are surprisingly comparable to those induced by strains that are not deficient in CyaA. This innovative approach could lead to advancements in vaccine efficacy against whooping cough.
Career Highlights: Throughout her career, Annabelle has held significant positions at esteemed institutions. She has worked at the National University of Singapore and Institut National de la Santé et de la Recherche Médicale, where she honed her skills in research and development. Her work has paved the way for new perspectives in the field of immunology and vaccine technology.
Collaborations: Annabelle Rui Fen Lim has collaborated with several distinguished researchers during her career, including Sylvie Claudette Alonso and Camille Locht. These partnerships have enriched her research endeavors and facilitated advancements in her projects, particularly those related to infectious diseases.
Conclusion: Annabelle Rui Fen Lim stands out as an influential inventor in the biomedical field, particularly for her innovative approach to vaccine development against pertussis. With her remarkable patent, collaborative efforts, and esteemed career, she continues to be a key contributor to advancements in medical research. Her work not only underscores the importance of scientific innovation but also demonstrates the potential impact of vaccines on public health.